Atlas Trials

A Study to Evaluate the Efficacy and Safety of VCT220 in Obesity Chinese Population

Clinical trial NCT06569355 · COMPLETED

Trial details

NCT number
NCT06569355
Sponsor
Vincentage Pharma Co., Ltd
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
ObesityOverweight
Start date
2023-12-27
Primary completion
2024-07-13
Enrollment
250

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.